Home > Balance Sheet > BETA DRUGS

BETA DRUGS
Total Current Liabilities

    Back to Balance Sheet
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹113 Cr₹94 Cr₹70 Cr₹55 Cr₹37 Cr

What is the latest Total Current Liabilities ratio of BETA DRUGS ?

The latest Total Current Liabilities ratio of BETA DRUGS is ₹113 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹113 Cr
Mar2024₹94 Cr
Mar2023₹70 Cr
Mar2022₹55 Cr
Mar2021₹37 Cr

How is Total Current Liabilities of BETA DRUGS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹113 Cr
20.11
Mar2024 ₹94 Cr
35.43
Mar2023 ₹70 Cr
27.09
Mar2022 ₹55 Cr
49.90
Mar2021 ₹37 Cr -

Compare Total Current Liabilities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,570.3 Cr -5.1% 7% 32.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-5.1%

7%

32.4%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses